Triamcinolone Acetonide NDC 55150-384

NDC codes

FDA NDC Directory

Product NDC (as listed)55150-384Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55150-0384Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55150-384-01	55150038401	1 VIAL, MULTI-DOSE in 1 CARTON (55150-384-01) / 5 mL in 1 VIAL, MULTI-DOSEMarketed from Jul 5, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Triamcinolone Acetonide
Generic name (nonproprietary): triamcinolone acetonide
Active ingredients: Triamcinolone acetonide — 40 mg/mL
Dosage form: Injection, Suspension
Route: Intra-articular, Intramuscular, Soft tissue
Labeler: Eugia US LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212400
Marketing start: Jul 5, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 55150-384_dab18c1a-6fc9-4427-b44f-e34e0168450eSPL ID dab18c1a-6fc9-4427-b44f-e34e0168450eSPL set ID d9abdda5-80e3-407c-b636-9cc5fc438098RxCUI 1085754UNII F446C597KAUPC 0355150384013, 0355150385010
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N455150038401 followed by a unit qualifier and the quantity

Package 55150-0384-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 15, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Intramuscular Where oral therapy is not feasible, injectable corticosteroid therapy, including triamcinolone acetonide injectable suspension is indicated for intramuscular use as follows: Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome). Endocrine disorders: Primary …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 212400

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212400
Product	Strength	Form · route	Labeler	Product NDC
Triamcinolone Acetonide	Triamcinolone acetonide 40 mg/mL	Injection, SuspensionIntra-articular, Intramuscular, Soft tissue	Eugia US LLC	55150-385